These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1361533)

  • 21. Influence of liver cirrhosis upon the pharmacokinetics of tenoxicam.
    Crevoisier C; Zaugg PY; Heizmann P; Meyer J
    Int J Clin Pharmacol Res; 1989; 9(5):327-34. PubMed ID: 2625372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacokinetics of tenoxicam.
    Nilsen OG
    Clin Pharmacokinet; 1994 Jan; 26(1):16-43. PubMed ID: 8137596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The elimination profiles of tenoxicam and hydroxytenoxicam in equine urine and serum after a 200-mg oral dose.
    Marland A; Sarkar P; Leavitt R
    J Anal Toxicol; 1999; 23(4):237-41. PubMed ID: 10445485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of age on the pharmacokinetics of tenoxicam in comparison to other non-steroidal anti-inflammatory drugs (NSAIDs).
    Schmitt M; Guentert TW
    Scand J Rheumatol Suppl; 1989; 80():86-9. PubMed ID: 2688082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of concurrent aspirin upon plasma concentrations of tenoxicam.
    Day RO; Paull PD; Lam S; Swanson BR; Williams KM; Wade DN
    Br J Clin Pharmacol; 1988 Oct; 26(4):455-62. PubMed ID: 3190995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of food and various antacids on the absorption of tenoxicam.
    Day RO; Lam S; Paull P; Wade D
    Br J Clin Pharmacol; 1987 Sep; 24(3):323-8. PubMed ID: 3499163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of tenoxicam at different dosage regimes.
    Scaglione F; Demartini G; Dugnani S; Fraschini F; Triscari FA
    Farmaco; 1993 Sep; 48(9):1321-5. PubMed ID: 8259988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraocular and plasma kinetics of tenoxicam in rabbits.
    Del Puppo M; Kienle MG; Ratiglia R; Galimberti D; Acerbi G; Boerci L; Marabini L; Chiesara E
    Graefes Arch Clin Exp Ophthalmol; 1993 Feb; 231(2):115-7. PubMed ID: 8444358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human serum albumin conformational changes as induced by tenoxicam and modified by simultaneous diazepam binding.
    Brée F; Urien S; Nguyen P; Tillement JP; Steiner A; Vallat-Molliet C; Testa B; Visy J; Simonyi M
    J Pharm Pharmacol; 1993 Dec; 45(12):1050-3. PubMed ID: 7908973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The binding of oxicam derivatives to human serum albumin].
    Kinawi A; Siebler D
    Arzneimittelforschung; 1988 Aug; 38(8):1089-92. PubMed ID: 3264167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neither cimetidine nor probenecid affect the pharmacokinetics of tenoxicam in normal volunteers.
    Day RO; Geisslinger G; Paull P; Williams KM
    Br J Clin Pharmacol; 1994 Jan; 37(1):79-81. PubMed ID: 8148224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph distribution of different non-steroidal anti-inflammatory drugs assessed by microsurgical cannulation of the thoracic duct in rat.
    Ionac M; Oelkers R; Brune K; Geisslinger G; Bordos D
    Rom J Intern Med; 1996; 34(3-4):239-51. PubMed ID: 9167225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tenoxicam i.v. in major gynaecological surgery--pharmacokinetic, pain relief and haematological effects.
    Jones RD; Miles W; Prankerd R; Lang C; Chilvers M; Lo SK
    Anaesth Intensive Care; 2000 Oct; 28(5):491-500. PubMed ID: 11094663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of furosemide in anephric patients and in normal subjects.
    Andreasen F; Hansen HE; Mikkelsen E
    Eur J Clin Pharmacol; 1978 Mar; 13(1):41-8. PubMed ID: 639832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
    Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
    Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of tenoxicam in healthy human volunteers.
    Heintz RC; Guentert TW; Enrico JF; Dubach UC; Brandt R; Jeunet FS
    Eur J Rheumatol Inflamm; 1984; 7(2):33-44. PubMed ID: 6336292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-inflammatory activity and gastric lesions induced by zinc-tenoxicam.
    Nascimento JW; Santos LH; Nothenberg MS; Coelho MM; Oga S; Tagliati CA
    Pharmacology; 2003 Jun; 68(2):64-9. PubMed ID: 12711832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. II. Differential effects on the biliary excretion.
    Lin JH; Yeh KC; Duggan DE
    Drug Metab Dispos; 1985; 13(5):608-13. PubMed ID: 2865112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative biochemical pharmacology of the oxicams.
    Fenner H
    Scand J Rheumatol Suppl; 1987; 65():97-101. PubMed ID: 3500509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of tenoxicam on intra-abdominal adhesion prevention in a rat model.
    Yilmazlar T; Kaya E; Gürpinar E; Emiroğlu H
    J Int Med Res; 1996; 24(4):352-7. PubMed ID: 8854289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.